Option Care Health (OPCH) Q2 FY26 earnings call

Option Care Health delivered a strong second quarter, exceeding expectations across key financial metrics, driven by robust acute therapy growth and stabilization in its chronic inflammatory disease portfolio. The company is actively advancing strategic initiatives, including commercial team enhancements and technology investments, to improve operational efficiency and reaccelerate long-term growth, despite acknowledging ongoing work to fully realize its potential. Capital allocation remains disciplined, with significant share repurchases executed during the quarter.